JH-VIII-49
Product Specifications
UNSPSC Description
JH-VIII-49 (compound 10) is a potent and selective CDK8 inhibitor (IC50=16 nM) with excellent biological activity. JH-VIII-49 promotes CDK8 inhibition through its steroid backbone design. JH-VIII-49 can be used in the synthesis of PROTAC as a target protein ligand of JH-XI-10-02 (HY-111518)[1][2].
Target Antigen
CDK; Ligands for Target Protein for PROTAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jh-viii-49.html
Smiles
C[C@@]12[C@](CC[C@@H]2C3=CC4=C(C=CN=C4)C=C3)([H])[C@@]5([H])[C@]([C@@]6(C(C[C@H](CC6)N(C)C)=CC5)C)([H])CC1
Molecular Weight
428.65
References & Citations
[1]Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-125001/JH-VIII-49-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-125001/
Clinical Information
No Development Reported
CAS Number
2209084-73-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LMB873Mu 96 Tests
Multiplex Assay Kit for Cluster Of Differentiation 19 (CD19), etc. by FLIA (Flow Luminescence Immunoassay)
Ask
View Details 
